Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 25

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 25
---
 from this offering. See “Underwriting—Conflicts
of Interest and Other Relationships.” Baird will pay a referral fee to an affiliate of The Huntington National Bank, one of the lenders under our Credit Facility, in connection
with this offering.

Pending the permanent use of the net proceeds
of this offering, the Operating Partnership may invest the net proceeds in interest-bearing short-term investment-grade securities, money-market
accounts or other investments that are consistent with our intention to maintain our qualification as a REIT.

<div align='center'>S-14

DESCRIPTION OF SERIES B PREFERRED STOCK</div>

This prospectus supplement summarizes specific terms and provisions of the Series B Preferred Stock, and to the extent inconsistent with the description of our preferred stock included in the accompanying prospectus, this summary supersedes that description. The following summary of the terms and provisions of the Series B Preferred Stock does not purport to be complete and is in all respects subject to, and qualified in its entirety by reference to our charter, including the Articles Supplementary, our bylaws and Maryland law.

For purposes of this section, references to “we,” “our” and “our company” refer only to Global Medical REIT Inc. and not to any of its subsidiaries.

General

Our charter provides that we may issue up to 10,000,000
shares of preferred stock, $0.001 par value per share, of which 3,105,000 shares of preferred stock have been classified as shares of
our Series A Preferred Stock. Our charter authorizes the Board of Directors to amend our charter to increase or decrease the aggregate
number of authorized shares or the number of shares of any class or series without stockholder approval. Our Board of Directors may authorize
the issuance of preferred stock in one or more classes or series and may determine, with respect to any such class or series, the rights,
preferences, privileges and restrictions of the preferred stock of that class or series.

Reopening

The Articles Supplementary will permit us to “reopen”
this series, without the consent of the holders of our Series B Preferred Stock, in order to issue additional shares of Series B
Preferred Stock from time to time. Any additional Series B Preferred Stock will have the same terms as the Series B Preferred
Stock that we are issuing in this offering. These additional Series B Preferred Stock will, together with the Series B Preferred
Stock being issued in this offering, constitute a single series of securities.

Maturity

The Series B Preferred Stock has no stated
maturity